Viewing Study NCT00119366


Ignite Creation Date: 2025-12-24 @ 4:34 PM
Ignite Modification Date: 2026-02-22 @ 5:23 PM
Study NCT ID: NCT00119366
Status: TERMINATED
Last Update Posted: 2022-12-12
First Post: 2005-07-12
Is Gene Therapy: True
Has Adverse Events: True

Brief Title: Iodine I 131 Monoclonal Antibody BC8, Fludarabine Phosphate, Total Body Irradiation, and Donor Stem Cell Transplant Followed by Cyclosporine and Mycophenolate Mofetil in Treating Patients With Advanced Acute Myeloid Leukemia or Myelodysplastic Syndrome
Sponsor: Fred Hutchinson Cancer Center
Organization:

Organization Data

Organization:
Class: OTHER
Study ID: 1809.00
Study Type: None
Study Domain: None
Study Link: None
Lead Sponsor:
Lead Sponsor Class: OTHER
Responsible Party:
Responsible Party Title:
Responsible Party Type: PRINCIPAL_INVESTIGATOR
Responsible Party Affiliation:
Old Name: None
Old Organization: None

Collaborators

Collaborators

Name Class View
None NIH View